Latest Insider Transactions at Inari Medical, Inc. (NARI)
This section provides a real-time view of insider transactions for Inari Medical, Inc. (NARI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inari Medical, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inari Medical, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 29
2024
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.67%
|
$150,000
$50.0 P/Share
|
|
Oct 29
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
40,000
-3.38%
|
$2,000,000
$50.05 P/Share
|
|
Oct 16
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
40,000
-3.16%
|
$1,800,000
$45.17 P/Share
|
|
Oct 01
2024
|
Kevin T Strange Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,041
-0.36%
|
$41,640
$40.63 P/Share
|
|
Oct 01
2024
|
Kevin T Strange Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,695
+10.53%
|
-
|
|
Oct 01
2024
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,222
-0.23%
|
$168,880
$40.63 P/Share
|
|
Oct 01
2024
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,120
-0.17%
|
$84,800
$40.63 P/Share
|
|
Oct 01
2024
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,063
-0.16%
|
$82,520
$40.63 P/Share
|
|
Oct 01
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,067
-0.29%
|
$82,680
$40.63 P/Share
|
|
Sep 16
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
40,000
-2.95%
|
$1,840,000
$46.0 P/Share
|
|
Sep 12
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-0.55%
|
$135,000
$45.51 P/Share
|
|
Sep 12
2024
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+1.62%
|
$0
$0.46 P/Share
|
|
Aug 20
2024
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.66%
|
$150,000
$50.0 P/Share
|
|
Aug 19
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
20,000
-2.84%
|
$1,000,000
$50.3 P/Share
|
|
Aug 16
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
40,000
-2.73%
|
$1,920,000
$48.95 P/Share
|
|
Aug 12
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.36%
|
$240,000
$48.25 P/Share
|
|
Aug 12
2024
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.64%
|
$0
$0.46 P/Share
|
|
Jul 22
2024
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.65%
|
$165,000
$55.23 P/Share
|
|
Jul 16
2024
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,480
-1.11%
|
$191,400
$55.16 P/Share
|
|
Jul 16
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
60,000
-0.77%
|
$3,360,000
$56.57 P/Share
|
|
Jul 15
2024
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
16,520
-1.69%
|
$908,600
$55.09 P/Share
|
|
Jul 12
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.37%
|
$270,000
$54.02 P/Share
|
|
Jul 12
2024
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.64%
|
$0
$0.46 P/Share
|
|
Jul 01
2024
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,063
-0.13%
|
$103,150
$50.19 P/Share
|
|
Jul 01
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
20,000
-2.42%
|
$1,000,000
$50.15 P/Share
|
|
Jul 01
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,067
-0.29%
|
$103,350
$50.19 P/Share
|
|
Jul 01
2024
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,222
-0.23%
|
$211,100
$50.19 P/Share
|
|
Jul 01
2024
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.64%
|
$150,000
$50.08 P/Share
|
|
Jul 01
2024
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,120
-0.16%
|
$106,000
$50.19 P/Share
|
|
Jun 21
2024
|
Rebecca Chambers Director |
SELL
Open market or private sale
|
Direct |
260
-2.61%
|
$11,700
$45.99 P/Share
|
|
Jun 17
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
40,000
-1.17%
|
$1,760,000
$44.59 P/Share
|
|
Jun 12
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.35%
|
$235,000
$47.6 P/Share
|
|
Jun 12
2024
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.61%
|
$0
$0.46 P/Share
|
|
May 28
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
60,000
-6.48%
|
$3,000,000
$50.13 P/Share
|
|
May 28
2024
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.64%
|
$150,000
$50.0 P/Share
|
|
May 20
2024
|
Rebecca Chambers Director |
SELL
Open market or private sale
|
Direct |
964
-8.84%
|
$43,380
$45.39 P/Share
|
|
May 16
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
40,000
-2.09%
|
$1,840,000
$46.75 P/Share
|
|
May 13
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,000
-1.08%
|
$270,000
$45.59 P/Share
|
|
May 13
2024
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+3.1%
|
$0
$0.46 P/Share
|
|
May 01
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
38,549
-1.28%
|
$1,619,058
$42.76 P/Share
|
|
Apr 24
2024
|
Catherine M. Szyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,126
+15.54%
|
$173,292
$42.41 P/Share
|
|
Apr 24
2024
|
Robert Keith Warner Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,126
+25.35%
|
$173,292
$42.41 P/Share
|
|
Apr 24
2024
|
Donald B Milder Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,126
+1.57%
|
$173,292
$42.41 P/Share
|
|
Apr 24
2024
|
Jonathan D Root Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,126
+0.76%
|
$173,292
$42.41 P/Share
|
|
Apr 24
2024
|
Cynthia L Lucchese Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,126
+9.7%
|
$173,292
$42.41 P/Share
|
|
Apr 24
2024
|
Dana G Mead Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,126
+27.01%
|
$173,292
$42.41 P/Share
|
|
Apr 24
2024
|
William Hoffman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,126
+0.41%
|
$173,292
$42.41 P/Share
|
|
Apr 24
2024
|
Rebecca Chambers Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,126
+27.44%
|
$173,292
$42.41 P/Share
|
|
Apr 16
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
1,451
-0.14%
|
$58,040
$40.0 P/Share
|
|
Apr 12
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,000
-3.2%
|
$240,000
$40.96 P/Share
|